Noninvasive Assessment of Advanced Fibrosis Based on Hepatic Volume in Patients with Nonalcoholic Fatty Liver Disease

키워드

참고문헌 (51)

1. Angulo P, "Nonalcoholic fatty liver disease", N Engl J Med, 346, pp.1221~1231 (2002)
2. Rinella ME, "Nonalcoholic fatty liver disease: a systematic review", JAMA, 313, pp.2263~2273 (2015)
3. Fan JG, "Epidemiology of non-alcoholic fatty liver disease in China", J Hepatol, 50, pp.204~210 (2009)
4. Welsh JA, "Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988-1994 to 2007-2010", J Pediatr, 162, pp.496~500.e1 (2010)
5. Adams LA, "The natural history of nonalcoholic fatty liver disease: a population-based cohort study", Gastroenterology, 129, pp.113~121 (2005)
6. Ratziu V, "Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cir rhosis", Hepatology, 35, pp.1485~1493 (2002)
7. Kawamura Y, "Large-scale long-term follow-up study of Japanese patients with non-alcoholic fatty liver disease for the onset of hepatocellular carcinoma", Am J Gastroenterol, 107, pp.253~261 (2012)
8. Argo CK, "Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis", J Hepatol, 51, pp.371~379 (2009)
9. Angulo P, "Long-term mortality in nonalcoholic fatty liver disease: is liver histology of any prognostic significance", Hepatology, 51, pp.373~375 (2010)
10. Ascha MS, "The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis", Hepatology, 51, pp.1972~1978 (2010)
11. Piccinino F, "Complications following percutaneous liver biopsy: a multicentre retrospective study on 68,276 biopsies", J Hepatol, 2, pp.165~173 (1986)
12. Regev A, "Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection", Am J Gastroenterol, 97, pp.2614~2618 (2002)
13. Colloredo G, "Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease", J Hepatol, 39, pp.239~244 (2003)
14. Ratziu V, "Sampling variability of liver biopsy in nonalcoholic fatty liver disease", Gastroenterology, 128, pp.1898~1906 (2005)
15. Angulo P, "Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease", Gastroenterology, 149, pp.389~397.e10 (2015)
16. Frydrychowicz A, "Hepatobiliary MR imaging with gadolinium-based contrast agents", J Magn Reson Imaging, 35, pp.492~511 (2012)
17. Bashir MR, "Hepatocellular carcinoma in a North American population: does hepatobiliary MR imaging with Gd-EOB-DTPA improve sensitivity and confidence for diagnosis", J Magn Reson Imaging, 37, pp.398~406 (2013)
18. Higaki A, "Prognosis of small hepatocellular nodules detected only at the hepatobiliary phase of Gd-EOB-DTPA-enhanced MR imaging as hypointensity in cirrhosis or chronic hepatitis", Eur Radiol, 24, pp.2476~2481 (2014)
19. Kudo M, "JSH consensus-based clinical practice guidelines for the management of hepatocellular carcinoma: 2014 update by the Liver Cancer Study Group of Japan", Liver Cancer, 3, pp.458~468 (2014)
20. Sano K, "Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced MR imaging", Radiology, 261, pp.834~844 (2011)
21. Böttcher J, "Detection and classification of different liver lesions: comparison of Gd-EOB-DTPA-enhanced MRI versus multiphasic spiral CT in a clinical single centre investigation", Eur J Radiol, 82, pp.1860~1869 (2013)
22. Kawamura Y, "Three-dimensional magnetic resonance imaging for stringent diagnosis of advanced fibrosis associated with nonalcoholic steatohepatitis", Hepatol Int, 7, pp.850~858 (2013)
23. Ogura S, "Magnetic resonance laparoscopy: a new non-invasive technique for the assessment of chronic viral liver disease", Hepatol Res, 43, pp.836~845 (2013)
24. Zhou XP, "Liver volume variation in patients with virus-induced cirrhosis: findings on MDCT", AJR Am J Roentgenol, 189, pp.W153~W159 (2007)
25. Kleiner DE, "Design and validation of a histological scoring system for nonalcoholic fatty liver disease", Hepatology, 41, pp.1313~1321 (2005)
26. Wai CT, "A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C", Hepatology, 38, pp.518~526 (2003)
27. Harrison SA, "Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease", Gut, 57, pp.1441~1447 (2008)
28. Tan KC, "The right posterior hepatic notch sign", Radiology, 248, pp.317~318 (2008)
29. Piton A, "Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. MULTIVIRC group", Hepatology, 27, pp.1213~1219 (1998)
30. Leroy V, "Diagnostic accuracy, reproducibility and robustness of fibrosis blood tests in chronic hepatitis C: a meta-analysis with individual data", Clin Biochem, 41, pp.1368~1376 (2008)
31. Castera L, "Non-invasive assessment of liver fibrosis in chronic hepatitis C", Hepatol Int, 5, pp.625~634 (2011)
32. Loaeza-del-Castillo A, "AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis", Ann Hepatol, 7, pp.350~357 (2008)
33. Calès P, "Comparison of blood tests for liver fibrosis specific or not to NAFLD", J Hepatol, 50, pp.165~173 (2009)
34. Fujii H, "Noninvasive laboratory tests proposed for predicting cirrhosis in patients with chronic hepatitis C are also useful in patients with non-alcoholic steatohepatitis", J Gastroenterol, 44, pp.608~614 (2009)
35. Kruger FC, "APRI: a simple bedside marker for advanced fibrosis that can avoid liver biopsy in patients with NAFLD", NASH, 2011, pp.101, 477~480
36. Subasi CF, "Comparison of noninvasive scores for the detection of advanced fibrosis in patients with nonalcoholic fatty liver disease", Eur J Gastroenterol Hepatol, 27, pp.137~141 (2015)
37. Wong VW, "Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease", Hepatology, 51, pp.454~462 (2010)
38. Ruffillo G, "Comparison of NAFLD fibrosis score and BARD score in predicting fibrosis in nonalcoholic fatty liver disease", J Hepatol, 54, pp.160~163 (2011)
39. 이태훈, "Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: An Enhanced Model of BARD Score", Gut and Liver, 7(3), pp.323~328 (2013), 거트앤리버 발행위원회
40. Cassinotto C, "Liver stiffness in nonalcoholic fatty liver disease: a comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy", Hepatology, 63, pp.1817~1827 (2016)
41. Shen F, "Impact of skin capsular distance on the performance of controlled attenuation parameter in patients with chronic liver disease", Liver Int, 35, pp.2392~2400 (2015)
42. Kumagai E, "Appropriate use of virtual touch quantification and FibroScan M and XL probes according to the skin capsular distance", J Gastroenterol, 51, pp.496~505 (2016)
43. Kim D, "Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography", Radiology, 268, pp.411~419 (2013)
44. Loomba R, "Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study", Hepatology, 60, pp.1920~1928 (2014)
45. Venkatesh SK, "Magnetic resonance elastography of liver: clinical applications", J Comput Assist Tomogr, 37, pp.887~896 (2013)
46. Saito K, "Gd-EOB-DTPA enhanced MRI for hepatocellular carcinoma: quantitative evaluation of tumor enhancement in hepatobiliary phase", Magn Reson Med Sci, 4, pp.1~9 (2005)
47. Golfieri R, "Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to Dynamic MRI in the detection of hypovascular small (≤ 2 cm) HCC in cirrhosis", Eur Radiol, 21, pp.1233~1242 (2011)
48. Hashimoto E, "Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis", J Gastroenterol, 44(Suppl 19), pp.89~95 (2009)
49. Yoshioka Y, "Nonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma, and burnt-out NASH", J Gastroenterol, 39, pp.1215~1218 (2004)
50. Reiner CS, "Preoperative liver volumetry: how does the slice thickness influence the multidetector computed tomography- and magnetic resonance-liver volume measurements", J Comput Assist Tomogr, 33, pp.390~397 (2009)
51. Laakso MP, "MRI volumetry of the hippocampus: the effect of slice thickness on volume formation", Magn Reson Imaging, 15, pp.263~265 (1997)

관련 논문AI추천